cRGD-Modified Benzimidazole-based pH-Responsive Nanoparticles for Enhanced Tumor Targeted Doxorubicin Delivery.
Liu J, Liu Q, Yang C, Sun Y, Zhang Y, Huang P, Zhou J, Liu Q, Chu L, Huang F, Deng L, Dong A, Liu J.
Liu J, et al. Among authors: huang p, huang f.
ACS Appl Mater Interfaces. 2016 May 4;8(17):10726-36. doi: 10.1021/acsami.6b01501. Epub 2016 Apr 19.
ACS Appl Mater Interfaces. 2016.
PMID: 27058429